Announcements Trials
Browse Landscape

Phase

Phase 2 2Phase 1/2 2Phase 1 2Phase 3 1

Status

Terminated 1Completed 1

Sponsor Class

NIH 1INDUSTRY 1

Study Type

Interventional 2

Sponsor

Cancer Type

Tumor-Agnostic 1Lymphoid 1

Conditions

Recurrence 2Polycystic Ovary Syndrome 2Pleural Effusion, Malignant 2Neoplasms 2Neoplasm Metastasis 2Mesothelioma, Malignant 2Triple Negative Breast Neoplasms 1Lymphoma, Follicular 1Lymphoma, B-Cell 1Carcinoma, Non-Small-Cell Lung 1

Interventions

pembrolizumab 82Paclitaxel 71Gemcitabine 66Carboplatin 61Cisplatin 46Docetaxel 44Bevacizumab 41Nivolumab 33Irinotecan 31Fluorouracil 29Pemetrexed 28Cyclophosphamide 26Cetuximab 26Capecitabine 26Erlotinib Hydrochloride 22venetoclax 21trametinib 21Leucovorin 20Sorafenib 17Albumin-Bound Paclitaxel 17Afatinib 17130-nm albumin-bound paclitaxel 17Topotecan 16Radiotherapy 16Oxaliplatin 16fludarabine 15regorafenib 14budigalimab 14atezolizumab 14Ipilimumab 14

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 1 × Neoplasms × Pharmaceutical Preparations × Clear all
NCT00001572 2017-07-02

Vaccination of Follicular Lymphomas With Tumor-Derived Immunoglobulin Idiotype

National Institutes of Health Clinical Center (CC)

Phase 1 Completed
21 enrolled
Lymphoid

Lymphoma, Follicular, Neoplasms, Lymphoma, B-Cell

NCT01558687 2014-02-04

Cilengitide Imaging Trial in Glioblastoma

Merck KGaA, Darmstadt, Germany

Phase 1 Terminated
1 enrolled
Tumor-Agnostic

Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡